nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0297	0.0297	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0297	0.0297	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0293	0.0293	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0293	0.0293	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0286	0.0286	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0265	0.0265	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0265	0.0265	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0256	0.0256	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HCRT—narcolepsy	0.0244	0.0244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0241	0.0241	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0221	0.0221	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0218	0.0218	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—PENK—narcolepsy	0.0214	0.0214	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQA1—narcolepsy	0.0206	0.0206	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0196	0.0196	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0196	0.0196	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQB1—narcolepsy	0.0192	0.0192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.019	0.019	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—TRH—narcolepsy	0.0185	0.0185	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—TRH—narcolepsy	0.0182	0.0182	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0165	0.0165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0161	0.0161	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HCRTR2—narcolepsy	0.015	0.015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HCRTR1—narcolepsy	0.015	0.015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DRB1—narcolepsy	0.0146	0.0146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—P2RY11—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—NPS—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—TAC1—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—NPS—narcolepsy	0.0132	0.0132	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HCRT—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.012	0.012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.012	0.012	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—PENK—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.00997	0.00997	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TRH—narcolepsy	0.00931	0.00931	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00888	0.00888	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00845	0.00845	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00845	0.00845	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—P2RY11—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HRH3—narcolepsy	0.00816	0.00816	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00807	0.00807	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HCRTR1—narcolepsy	0.00768	0.00768	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HCRTR2—narcolepsy	0.00768	0.00768	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—P2RY11—narcolepsy	0.00741	0.00741	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00722	0.00722	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HCRT—narcolepsy	0.00694	0.00694	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—narcolepsy	0.00691	0.00691	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPS—narcolepsy	0.00676	0.00676	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TAC1—narcolepsy	0.00676	0.00676	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HCRT—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00624	0.00624	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PENK—narcolepsy	0.00619	0.00619	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PENK—narcolepsy	0.00562	0.00562	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00534	0.00534	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TRH—narcolepsy	0.00526	0.00526	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TRH—narcolepsy	0.00478	0.00478	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HRH3—narcolepsy	0.00461	0.00461	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HCRTR1—narcolepsy	0.00454	0.00454	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HCRTR2—narcolepsy	0.00454	0.00454	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—P2RY11—narcolepsy	0.00438	0.00438	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HRH3—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—HTR2A—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPS—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TAC1—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HCRT—narcolepsy	0.00372	0.00372	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TAC1—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPS—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PENK—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TRH—narcolepsy	0.00282	0.00282	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HRH3—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HTR2A—narcolepsy	0.0023	0.0023	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HTR2A—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPS—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TAC1—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HTR2A—narcolepsy	0.00123	0.00123	CbGpPWpGaD
